Clincosm LogoSign in Get a demo

idiopathic pulmonary fibrosis (ipf)

Showing 1 - 23 of 23
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Idiopathic Pulmonary Fibrosis (IPF) Trial in United States (INS018_055, Placebo)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis (IPF)
  • Los Angeles, California
  • +8 more
Jul 27, 2023

Idiopathic Pulmonary Fibrosis (IPF) Trial in China, United States (INS018_055, Placebo)

Recruiting
  • Idiopathic Pulmonary Fibrosis (IPF)
  • Los Angeles, California
  • +9 more
Jul 6, 2023

Idiopathic Pulmonary Fibrosis (IPF) Trial in United States (Saracatinab, Placebo)

Recruiting
  • Idiopathic Pulmonary Fibrosis (IPF)
  • Denver, Colorado
  • +3 more
Jan 27, 2023

Interstitial Lung Disease (ILD), Idiopathic Pulmonary Fibrosis (IPF) Trial in United States

Active, not recruiting
  • Interstitial Lung Disease (ILD)
  • Idiopathic Pulmonary Fibrosis (IPF)
    • Birmingham, Alabama
    • +41 more
    Aug 12, 2022

    Idiopathic Pulmonary Fibrosis (IPF) Trial (XFB-19, Placebo)

    Not yet recruiting
    • Idiopathic Pulmonary Fibrosis (IPF)
    • (no location specified)
    Jul 14, 2022

    Idiopathic Pulmonary Fibrosis (IPF) Trial (ANG-3070, Placebo)

    Not yet recruiting
    • Idiopathic Pulmonary Fibrosis (IPF)
    • (no location specified)
    Jun 8, 2022

    Idiopathic Pulmonary Fibrosis (IPF) Trial in Worldwide (GB0139, Placebo)

    Active, not recruiting
    • Idiopathic Pulmonary Fibrosis (IPF)
    • Andalusia, Alabama
    • +119 more
    May 23, 2022

    Healthy Participants, Idiopathic Pulmonary Fibrosis (IPF) Trial in New Haven (18F-BMS-986327)

    Recruiting
    • Healthy Participants
    • Idiopathic Pulmonary Fibrosis (IPF)
    • 18F-BMS-986327
    • New Haven, Connecticut
      Yale Positron Emission Tomography Center
    Mar 30, 2022

    Airway, Blood and/or Urine Specimens From Research Studies

    Recruiting
    • Chronic Obstructive Pulmonary Disease (COPD)
    • +5 more
      • New York, New York
        Weill Cornell Medical College and Weill Cornell Medical Center,
      Mar 29, 2022

      Idiopathic Pulmonary Fibrosis (IPF) Trial in Manchester (TD-1058, Placebo)

      Terminated
      • Idiopathic Pulmonary Fibrosis (IPF)
      • Manchester, United Kingdom
        Theravance Biopharma Investigational Site
      Feb 7, 2022

      Idiopathic Pulmonary Fibrosis (IPF) Trial in Shanghai (ZSP1603, Placebo)

      Recruiting
      • Idiopathic Pulmonary Fibrosis (IPF)
      • Shanghai, Shanghai, China
        Shanghai Lung Hospital
      Nov 3, 2021

      Genetics of IPF - Screening Study for Family Members

      Recruiting
      • Idiopathic Pulmonary Fibrosis (IPF)
      • High Resolution CT scan of the chest
      • +2 more
      • Aurora, Colorado
        University of Colorado Anschutz Medical Campus
      Sep 29, 2021

      Idiopathic Pulmonary Fibrosis (IPF) Trial in Aurora (N-acetyl cysteine then Placebo, Placebo then N-acetyl cysteine)

      Withdrawn
      • Idiopathic Pulmonary Fibrosis (IPF)
      • N-acetyl cysteine then Placebo
      • Placebo then N-acetyl cysteine
      • Aurora, Colorado
        University of Colorado Anschutz Medical Campus
      Jun 3, 2021

      Idiopathic Pulmonary Fibrosis (IPF) Trial in Miami (Allogeneic Adult Human Mesenchymal Stem Cells (hMSCs), matched )

      Terminated
      • Idiopathic Pulmonary Fibrosis (IPF)
      • Allogeneic Adult Human Mesenchymal Stem Cells (hMSCs)
      • matched placebo
      • Miami, Florida
        Interdisciplinary Stem Cell Institute / University of Miami
      Mar 5, 2021

      Idiopathic Pulmonary Fibrosis (IPF) Trial in Taipei (MG-S-2525)

      Completed
      • Idiopathic Pulmonary Fibrosis (IPF)
      • Taipei, Taiwan
        Taipei Medical University Hospital
      Aug 31, 2020

      Idiopathic Pulmonary Fibrosis (IPF) Trial (Morphine HCl, Placebo)

      Unknown status
      • Idiopathic Pulmonary Fibrosis (IPF)
      • Morphine hydrochloride
      • Placebo
      • (no location specified)
      Jul 30, 2020

      Discovery for Novel Drug Development in Idiopathic Pulmonary

      Completed
      • Idiopathic Pulmonary Fibrosis (IPF)
        • San Francisco, California
          University of California, San Francisco
        Jul 29, 2020

        Idiopathic Pulmonary Fibrosis (IPF) Trial in Salt Lake City (BMS-986278, Pirfenidone)

        Completed
        • Idiopathic Pulmonary Fibrosis (IPF)
        • Salt Lake City, Utah
          PRA Health Sciences - Salt Lake
        May 14, 2020

        Idiopathic Pulmonary Fibrosis (IPF) Trial in Winston-Salem, San Antonio (Dasatinib + Quercetin, Placebo)

        Completed
        • Idiopathic Pulmonary Fibrosis (IPF)
        • Dasatinib + Quercetin
        • Placebo
        • Winston-Salem, North Carolina
        • +1 more
        May 8, 2020

        Idiopathic Pulmonary Fibrosis (IPF) Trial in United States (BG00011, Placebo)

        Completed
        Has Results
        • Idiopathic Pulmonary Fibrosis (IPF)
        • San Francisco, California
        • +9 more
        Feb 12, 2020

        Idiopathic Pulmonary Fibrosis (IPF) Trial in Canada (PBI4050)

        Completed
        • Idiopathic Pulmonary Fibrosis (IPF)
        • Vancouver, British Columbia, Canada
        • +4 more
        Apr 15, 2019

        Idiopathic Pulmonary Fibrosis (IPF) Trial in Schönau Am Königssee (Medical air, Oxygen (2Liter/min), Oxygen (4Liter/min))

        Completed
        • Idiopathic Pulmonary Fibrosis (IPF)
        • Medical air
        • +2 more
        • Schönau Am Königssee, Germany
          Schoen Klinik Berchtesgadener Land
        Dec 3, 2018

        Idiopathic Pulmonary Fibrosis (IPF) Trial in Baltimore (Thalidomide)

        Completed
        • Idiopathic Pulmonary Fibrosis (IPF)
        • Baltimore, Maryland
          Johns Hopkins School of Medicine
        Jun 18, 2010